Connect with us

Announcements

MediPharm Labs Announces a Giant Leap in its Australian Cannabis Market Status

Gregory Smith

Published

on

MediPharm Labs Announces a Giant Leap in its Australian Cannabis Market Status
- Ad -

MediPharm Labs Corp. has announced that its subsidiary MediPharm Labs Australia Pty Ltd. has entered an agreement with a licensed Australian cannabis producer among other vital partnerships in advancing its Australian CBD market position.

Creating Australian Supply Partnerships

The company has also entered multi-year agreements with three Australian ODC approved cultivators such as BBS Pharmaceuticals. Warren Everitt, MediPharm Labs Australia Managing Director, confirmed this and added that other letters of intent were in their possession.

Picking up Speed in Australia

In Wonthaggi, Victoria, a state-of-the-art extraction and manufacturing facility is under construction and should be completed by the end of this year.

MediPharm Labs Australia received their cannabis manufacturing license on May 21, 2019, and production is expected to kick off within the first half of 2020.

To facilitate development, the company has also made four senior leadership appointments.

A Global Supply Chain Platform and Trendsetter

The Australian wing is expected to launch the company to satisfy the Asia-Pacific region and serve as a model for future expansions of the company in other regions.

The Australian Cannabis Industry Awards gave MediPharm Labs Australia the 2019 innovation award. What's more, the company has been labeled a specialized processor on many Australian cultivator license applications.

Gilbert Smith is rolling into his double digit year of occupation as a professional writer and skilled freelancer who has been worked and been featured with many mainstream media publications including Cracked.com and a host of others. The personality blended in with plenty of humor will shine through as he continues to highlight the pearls of the coming age of CBD oil.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com